ArticleNucleic acids research2026
Systematic discovery of bacterial anti-phage systems through a protein domain-centric strategy.
Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Bacterial exposure to constant phage attack drives rapid diversification of anti-phage defense systems, often through the exchange of modular defensive domains. Here, we leverage this modularity signature to identify new defense systems by systematically searching for operons encoding known defensive domains in non-canonical configurations. Using this approach, we identified 39 848 candidate defense operons in Escherichia coli genomes. Annotation of the operons based on their shared defensive domains with known systems reveals that the operons represent variants of 82 defense families. Experimental testing of nine candidates validated six with anti-phage activity. These include DarTG and ietAS system variants that have acquired helicase modules, and a Gabija system in which a MazF-like protein replaces GajA, implying novel anti-phage mechanisms. We also identified a new clade of Pycsar that synergizes with type IV Thoeris to broaden phage protection. Our findings demonstrate that mining modular defensive domains provides a powerful strategy to predict and characterize new anti-phage systems, expanding the known repertoire of bacterial immunity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.